Sex Differences in Efficacy and Toxicity of Systemic Treatments: An Undervalued Issue in the Era of Precision Oncology

Affiliations

¹ Berna C. Özdemir, Lausanne University Hospital; and International Cancer Prevention Institute, Lausanne, Switzerland; Chantal Csajka, Lausanne University Hospital; and University of Lausanne, Lausanne, Switzerland; Gian-Paolo Dotto, International Cancer Prevention Institute; University of Lausanne, Lausanne, Switzerland; and Massachusetts General Hospital, Charlestown, MA; and Anna Dorothea Wagner, Lausanne University Hospital, Lausanne, Switzerland.

Berna C Özdemir et al. J Clin Oncol. 2018.

. 2018 Sep 10;36(26):2680-2683.

doi: 10.1200/JCO.2018.78.3290. Epub 2018 Jul 13.

¹ Berna C. Özdemir, Lausanne University Hospital; and International Cancer Prevention Institute, Lausanne, Switzerland; Chantal Csajka, Lausanne University Hospital; and University of Lausanne, Lausanne, Switzerland; Gian-Paolo Dotto, International Cancer Prevention Institute; University of Lausanne, Lausanne, Switzerland; and Massachusetts General Hospital, Charlestown, MA; and Anna Dorothea Wagner, Lausanne University Hospital, Lausanne, Switzerland.

No abstract available

Comment in

Reply to L. Pala et al.
Wagner AD, Özdemir B, Csajka C. Wagner AD, et al. J Clin Oncol. 2019 Feb 10;37(5):439-440. doi: 10.1200/JCO.18.01668. Epub 2018 Dec 28. J Clin Oncol. 2019. PMID: 30592638 No abstract available.
Sex Differences in Efficacy and Toxicity of Systemic Cancer Treatments: Role of the Microbiome.
Pala L, Nezi L, De Pas T, Pennacchioli E, Cocorocchio E, Ferrucci P, Conforti F, Goldhirsch A. Pala L, et al. J Clin Oncol. 2019 Feb 10;37(5):439. doi: 10.1200/JCO.18.01270. Epub 2018 Dec 28. J Clin Oncol. 2019. PMID: 30592644 No abstract available.